Azitra (AZTR) Accumulated Expenses (2022 - 2026)
Azitra (AZTR) posted Accumulated Expenses of $270511.0 for Q1 2026, up 36.98% on a QoQ basis from $197484.0 in Q4 2025, and down 42.12% year-over-year from $467394.0 in Q1 2025.
Azitra (AZTR) Accumulated Expenses (2022 - 2026) Analysis & Trends
Azitra's Accumulated Expenses history runs 5 years deep, the most recent figure standing at $270511.0 for Q1 2026.
- Quarterly Accumulated Expenses fell 42.12% year-over-year to $270511.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $270511.0 (down 42.12% YoY) and the FY2025 annual result came in at $197484.0, down 67.24% from the prior year.
- Accumulated Expenses was $270511.0 for Q1 2026 at Azitra, up from $197484.0 in the prior quarter.
- Across five years, Accumulated Expenses topped out at $602787.0 in Q4 2024 and bottomed at $197484.0 in Q4 2025.
- A 5-year average of $410592.0 and a median of $434103.0 in 2024 frame the typical range for Accumulated Expenses.
- Annual changes were most pronounced in 2024 — Accumulated Expenses soared 78.41% — and 2025, when it sank 67.24%.
- Azitra's Accumulated Expenses stood at $371010.0 in 2022, then advanced by 3.41% to $383668.0 in 2023, then soared by 57.11% to $602787.0 in 2024, then sank by 67.24% to $197484.0 in 2025, then surged by 36.98% to $270511.0 in 2026.
- Business Quant data shows AZTR's Accumulated Expenses at $270511.0 in Q1 2026, $197484.0 in Q4 2025, and $507329.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Nanobiotix | 1,792.52 Bn | 1,792.46 Bn | - |
| 2 | Akari Therapeutics | 999.95 Bn | 999.95 Bn | - |
| 3 | BeOne Medicines | 475.97 Bn | 471.17 Bn | 1.35 Bn |
| 4 | Vertex Pharmaceuticals | 124.91 Bn | 117.66 Bn | 2.59 Bn |
| 5 | Regeneron Pharmaceuticals | 72.31 Bn | 63.56 Bn | 3.31 Bn |
| 6 | Belite Bio | 62.01 Bn | 62.01 Bn | - |
| 7 | Argenx Se | 54.23 Bn | 49.04 Bn | 1.41 Bn |
| 8 | Alnylam Pharmaceuticals | 38.31 Bn | 35.30 Bn | 959.66 Mn |
| 9 | Revolution Medicines | 36.16 Bn | 36.16 Bn | - |
| 10 | Azitra | 2.05 Mn | 2.05 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 270,511.00 |
| Dec 31, 2025 | 197,484.00 |
| Sep 30, 2025 | 507,329.00 |
| Jun 30, 2025 | 513,166.00 |
| Mar 31, 2025 | 467,394.00 |
| Dec 31, 2024 | 602,787.00 |
| Sep 30, 2024 | 486,981.00 |
| Jun 30, 2024 | 434,103.00 |
| Mar 31, 2024 | 348,930.00 |
| Dec 31, 2023 | 383,668.00 |
| Sep 30, 2023 | 272,950.00 |
| Jun 30, 2023 | 481,383.00 |
| Dec 31, 2022 | 371,010.00 |